Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786396 · ClinicalTrials.gov registry record · NA
Directly Observed Therapy for Community-Released HIV+ Prisoners
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00786396 is a NA study that has completed, run by Yale University. The registered enrollment target is 151 participants.
The verdict
NCT00786396, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The aim of this study is to develop effective interventions for HIV-infected prisoners who are released to the community. The intervention that we will study will be directly observed therapy (DAART/DOT) and we will compare this to the current standard of care that involves self-administered therapy (SAT). All subjects will get transitional case management and all subjects with a prior history of opiate dependence will be offered opiate substitution therapy (buprenorphine or methadone). Hypotheses: * At the end of six months those receiving DAART will have a higher level of adherence to HAART as compared to the SAT group. * The DAART Intervention will result in subjects having lower viral loads and higher CD4 counts as compared to the SAT group. * At the end of six months, the DAART group will have a lower rate of recidivism to jail/prison as compared to the SAT group. * Over the year, the DAART group will be more likely to make repeated primary HIV care visits than the SAT group.
Interventions
- BEHAVIORAL Directly administered antiretroviral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2004-07 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786396
The ClinicalTrials.gov registry entry for NCT00786396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Directly administered antiretroviral therapy is the first listed.
NCT00786396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786396 about?
NCT00786396 is a clinical study titled "Directly Observed Therapy for Community-Released HIV+ Prisoners". The aim of this study is to develop effective interventions for HIV-infected prisoners who are released to the community. The intervention that we will study will be directly observed therapy (DAART/DOT) and we will compare this to the current standard of care that involves self-administered therapy...
What is the current status of trial NCT00786396?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2004-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00786396?
The interventions under investigation include: Directly administered antiretroviral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00786396?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.